* 1736 were enrolled (mean age, 73.0 years; 996 [57.4%] women) and 76% completed the trial:

* In the clinical trial, among people receiving donanemab, micro-bleeding occurred in 31.4% and brain swelling in 24%.
Mar 11, 2024
______
Couple other excerpts.

31% & 24%.

Wow.